Home > Income Statement > NATCO PHARMA

NATCO PHARMA
Profit After Tax

    Back to Income Statement
NATCO PHARMA is part of below Screeners ↓
Top Small Cap Stocks with Best Fundamentals
Top Undervalued Small Cap Stocks
COMMUNITY POLL
for NATCO PHARMA
Please provide your vote to see the results

NATCO PHARMA Last 5 Year Profit After Tax History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
Profit After Tax ₹1,883 Cr₹1,388 Cr₹715 Cr₹170 Cr₹442 Cr

What is the latest Profit After Tax of NATCO PHARMA ?

The latest Profit After Tax ratio of NATCO PHARMA is ₹1,883 Cr based on Mar2025 Consolidated results.
Year Profit After Tax
Mar2025₹1,883 Cr
Mar2024₹1,388 Cr
Mar2023₹715 Cr
Mar2022₹170 Cr
Mar2021₹442 Cr

How is Profit After Tax of NATCO PHARMA Trending?

Years Profit After Tax % Change
Mar2025 ₹1,883 Cr
35.66
Mar2024 ₹1,388 Cr
94.09
Mar2023 ₹715 Cr
320.76
Mar2022 ₹170 Cr
-61.57
Mar2021 ₹442 Cr -

Compare Profit After Tax of peers of NATCO PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
NATCO PHARMA ₹16,426.2 Cr -1.3% -4.6% -4.3% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹467,630.0 Cr -0.1% 0.5% 14% Stock Analytics
DIVIS LABORATORIES ₹218,972.0 Cr -0.9% 21.1% 25.6% Stock Analytics
TORRENT PHARMACEUTICALS ₹188,358.0 Cr -1.3% 1.1% 32.7% Stock Analytics
CIPLA ₹118,916.0 Cr 0.2% 2.1% -5.1% Stock Analytics
DR REDDYS LABORATORIES ₹97,824.0 Cr 0.2% -7.7% -7.5% Stock Analytics


NATCO PHARMA Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
NATCO PHARMA

-1.3%

-4.6%

-4.3%

SENSEX

0.5%

2.6%

-3.7%


You may also like the below Video Courses